Cryptogenic myocardial infarction in young patients: which is the optimal diagnostic and therapeutic management?
Cristina Giglioli1, Serena Fatucchi, Miroslava Stolcova
1Department of Heart and Vessels, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Insights
A young athlete experienced cryptogenic myocardial infarction (MI) and subsequent renal infarctions. Oral anticoagulants proved more effective than antiplatelets for secondary prevention in this case.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Cryptogenic myocardial infarction (MI) in young athletes necessitates a thorough diagnostic evaluation.
- Standard investigations for MI often fail to identify the underlying cause in younger individuals.
Observation:
- A 31-year-old athlete presented with inferior MI and normal coronary arteries, with no identifiable thrombophilia or other risk factors.
- The patient later developed multiple left renal infarctions despite initial antiplatelet therapy.
- Transesophageal echocardiography (TEE) ruled out cardiac sources of embolism, including patent foramen ovale.
Findings:
- Switching from antiplatelet therapy to oral anticoagulants led to the cessation of further embolic events.
- The patient remained free of embolic events at one-year follow-up after transitioning to anticoagulation.
Implications:
- This case highlights the potential role of TEE in the diagnostic workup of cryptogenic MI in young patients.
- It suggests that oral anticoagulants may be a preferred strategy over antiplatelets for secondary prevention in cryptogenic MI when the etiology remains unclear.
Abstract:
A 31-year-old athlete was admitted to our hospital for previous inferior myocardial infarction (MI), diagnosed by transthoracic echocardiography, myocardial scintigraphy, and cardiac magnetic resonance, while coronary angiography revealed normal coronary arteries. Laboratory investigations excluded acquired or inherited thrombophilia, immunologic disorders, cardiotropic agents infection, and drug abuse. Antiplatelet therapy was started but, after 15 days, he was rehospitalized with diagnosis of multiple left renal infarctions. A transesophageal echocardiography (TEE) was so performed which excluded a right-to-left shunt, suggestive of patent foramen ovale, or other cardioembolic sources in heart chambers and valve apparatus. Antiplatelet therapy was replaced with oral anticoagulants without any further embolic event at one-year follow-up. This case raises two important questions regarding young patients with cryptogenic MI. First, if TEE should be part of a complete diagnostic pathway; second, if oral anticoagulants should be preferred over antiplatelets for secondary prevention particularly when the cause of MI remains unknown.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy V: Interprofessional Care


